Brain-X

Brain-X is a peer-reviewed, fully open access interdisciplinary journal on brain, neuroscience and neurology, published by Wiley from 2023 on behalf of the Center for Evidence-Based and Translational Medicine of Wuhan University, with a first 2025 Journal Impact Factor of 6.4.《交叉脑科学》（Brain-X）是覆盖脑科学、神经科学与神经病学的同行评审完全开放获取交叉学科期刊，2023 年 3 月创刊，由（Wiley）代表武汉大学循证与转化医学中心出版，2025 年获得首个期刊影响因子 6.4。

Scope

• The journal publishes cutting-edge discoveries and technologies that provide novel insights into all aspects of brain, neuroscience and neurology.本刊发表为脑科学、神经科学与神经病学各领域提供新颖洞见的前沿发现与技术。
• The X in the name stands for the intersection of brain and neuroscience research with other disciplines, and interdisciplinary studies using mathematics, physics, chemistry, engineering, materials science or information science are strongly encouraged.刊名中的 X 代表脑与神经科学同其他学科的交叉，本刊大力鼓励运用数学、物理、化学、工程、材料科学或信息科学的交叉研究。
• Stated topics include aging and brain, brain-computer interface, brain injury and rehabilitation, brain-inspired computing and artificial intelligence, and brain-inspired 3D printing.所列主题包括衰老与脑、脑机接口、脑损伤与康复、类脑计算与人工智能以及类脑 3D 打印。
• Further areas are brain rhythm and disease, the brain-gut axis, cellular and molecular neuroscience, cerebral organoids, chemical neuroscience and clinical neurology.其他方向包括脑节律与疾病、脑-肠轴、细胞与分子神经科学、脑类器官、化学神经科学与临床神经病学。
• Computational neuroscience, cognitive neuroscience, crosstalk between the brain and other organs, nanoparticles for brain drug delivery and nerve regeneration materials are also covered.计算神经科学、认知神经科学、脑与其他器官的相互对话、脑部药物递送纳米颗粒与神经再生材料亦在覆盖范围内。
• The journal publishes original research articles, data articles, methods articles, reviews, perspectives, research letters, commentaries and correspondences.本刊发表原创研究论文、数据论文、方法学论文、综述、观点、研究简讯、评论与通信。
• Its stated mission is to promote interdisciplinarity and to serve as a platform for students, scientists and clinicians to share discoveries and perspectives.本刊以促进学科交叉为使命，致力于成为学生、科学家与临床医师分享发现与观点的平台。

History

• The journal was launched with Volume 1, Issue 1 in March 2023, and its inaugural editorial announced the filling of a gap, since no professional journal focused specifically on interdisciplinary approaches to brain and neuroscience research.本刊第 1 卷第 1 期于 2023 年 3 月出版，创刊社论指出当时尚无专门聚焦脑与神经科学交叉研究路径的专业期刊，本刊即为填补这一空白而生。^[1]
• The ISSN record lists John Wiley and Sons Australia of Melbourne as the publisher from 2023, with Wuhan University as the issuing body, and the journal community Brain-X Science was founded in October 2022 with sponsorship from Ainuohui Medical Technology.ISSN 记录显示本刊自 2023 年起由墨尔本的约翰·威利父子澳大利亚公司出版，发行方为武汉大学；期刊学术团体（Brain-X Science）于 2022 年 10 月成立，由（Ainuohui Medical Technology）赞助。
• A launch ceremony was held on 29 October 2023 at the Zhangjiang Science Hall in Shanghai, by which time three issues of the first volume had already appeared.创刊大会于 2023 年 10 月 29 日在上海张江科学会堂举行，此时本刊第 1 卷已出版三期。
• The journal is quarterly, appearing in four issues a year in a single annual volume, with Volume 1 dated 2023 and Volume 4 reached in 2026.本刊按季出版，每年一卷四期，第 1 卷始于 2023 年，2026 年已出至第 4 卷。
• It is fully open access under the Creative Commons Attribution licence, article publication charges applied from 21 January 2026 at 2,750 US dollars for research articles, with reduced charges for data, methods, letter, commentary and perspective items and waivers for correspondence, editorials and news.本刊完全开放获取，按知识共享署名许可发布，2026 年 1 月 21 日起研究论文的文章发表费为 2750 美元，数据论文、方法学论文、简讯、评论与观点类文章可享折扣，通信、社论与新闻类文章免收。
• The journal was indexed in the Emerging Sources Citation Index in August 2025 and received its first Journal Impact Factor of 6.4 for 2025, ranking in the 2025 Journal Citation Reports Q1 in neurosciences (48 of 330) and Q1 in computer science, artificial intelligence (48 of 210).本刊 2025 年 8 月被（Emerging Sources Citation Index）收录，2025 年获得首个期刊影响因子 6.4，在 2025 年 JCR 的神经科学（48/330）与计算机科学人工智能（48/210）两个类别均列 Q1。

Editors

• The Editor-in-Chief is Kunlin Jin, a tenured professor in the Department of Pharmacology and Neuroscience at the University of North Texas Health Science Center in Fort Worth, United States.主编为（Kunlin Jin），美国北德克萨斯大学健康科学中心药理学与神经科学系终身教授。
• Trained in medicine in China and after postdoctoral work at the University of California, San Francisco and the University of Pittsburgh, he joined the Buck Institute and later the University of North Texas, and he is known for showing that brain injury can stimulate stem cells to generate new neurons.他在中国接受医学训练，曾在加利福尼亚大学旧金山分校与匹兹堡大学从事博士后研究，后供职于巴克研究所与北德克萨斯大学，以发现脑损伤可刺激干细胞产生新神经元而知名。
• Jizong Zhao of Capital Medical University serves as Honorary Editor-in-Chief.首都医科大学的（Jizong Zhao）任名誉主编。
• The Associate Editors are Hak-Keung Lam (King's College London), Chunsheng Kang (Tianjin Medical University), Xiaoli Li (Beijing Normal University), Zhi-Qiang Li (Wuhan University), Fred Paas (Erasmus University Rotterdam) and Lina Yao (University of New South Wales).副主编包括伦敦国王学院的（Hak-Keung Lam）、天津医科大学的（Chunsheng Kang）、北京师范大学的（Xiaoli Li）、武汉大学的（Zhi-Qiang Li）、鹿特丹伊拉斯谟大学的（Fred Paas）与新南威尔士大学的（Lina Yao）。
• Editorial board members include Zhe-Sheng Chen (St. John's University), Xiaoqing Hu (University of Hong Kong), Linxin Li (University of Oxford), Noureddine Melikechi (University of Massachusetts Lowell), Navid Rabiee (Murdoch University), Zhouguang Wang (Albert Einstein College of Medicine), Jiajia Xue (Beijing University of Chemical Technology) and Fan Zhang (Harvard University).编委会成员包括圣约翰大学的（Zhe-Sheng Chen）、香港大学的（Xiaoqing Hu）、牛津大学的（Linxin Li）、马萨诸塞大学洛厄尔分校的（Noureddine Melikechi）、默多克大学的（Navid Rabiee）、阿尔伯特·爱因斯坦医学院的（Zhouguang Wang）、北京化工大学的（Jiajia Xue）与哈佛大学的（Fan Zhang）。
• Wiley lists a single anonymized peer review model with free-format submission, an acceptance rate of 19 per cent and a median of 28 days from acceptance to online publication, and submissions go through the ScholarOne system.（Wiley）公布的编辑政策为单匿名评审与自由格式投稿，录用率 19%，从接收到在线发表的中位时间为 28 天，稿件经（ScholarOne）系统提交。